Torrey Czech
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Torrey Czech has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Yoshito Nishimura
Division of Hematology and Oncology, Mayo Clinic, Rochester, MN 55901, USA
5 shared publications - Nobuhiko Kimura
Department of Medicine, John A. Burns School of Medicine, University of Hawai'i, 1356 Lusitana St., Room 715, Honolulu, HI 96813, USA
4 shared publications - Fumio Otsuka
Department of General Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan
2 shared publications - Hideharu Hagiya
Department of Infectious Diseases, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
2 shared publications - Krixie Silangcruz
University of Hawaii Honolulu, HI United States
2 shared publications - Parthav Shah
University of Hawaii Internal Medicine Residency Program, Honolulu, HI, United States
2 shared publications
Latest Publications
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A4169
Recurrent Squamous Cell Lung Cancer Presenting as Dyspnea Secondary to Distal Tracheal Mass
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A4169
Recurrent Squamous Cell Lung Cancer Presenting as Dyspnea Secondary to Distal Tracheal Mass
- Open Access
- 12 August 2022
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 13, 354
Cerebral toxoplasmosis in a patient with combined variable immunodeficiency
Background: Cerebral toxoplasmosis is an opportunistic infection in patients but has rarely been described in the setting of compromised humoral immunodeficiency. Prompt diagnosis and treatment of the infection is critical in the care of these patients. Medical management is the mainstay of treatment of the infection. There have been very few reports of surgical management of cerebral toxoplasmosis. Case Description: We describe the case of a 40-year-old male who presented with headache, memory deficits, weight loss, and left-sided weakness in the setting of a known but undiagnosed brain lesion identified 1 month prior. Imaging demonstrated a right basal ganglia lesion which was initially presumed to be malignancy. On further workup including a positive serum test and biopsy including polymerase chain reaction analysis, diagnosis was confirmed as toxoplasmosis. On further investigation, he was found to have deficiencies in immunoglobulins consistent with common variable immunodeficiency (CVID). The patient underwent craniotomy with surgical debulking as repeat imaging showed increased size of mass with new satellite lesions and worsening hydrocephalus. Conclusion: Cerebral toxoplasmosis is an important differential to consider in cases of intracerebral lesions and should not necessarily be excluded in the absence of compromised cellular immunity. In cases where there is no immunocompromised state and malignancy cannot immediately be established, CVID should be considered as an etiology. Due to the subtlety of CVID diagnosis, careful attention should be paid to history taking and workup for CVID should be considered as soon as possible. Surgical removal of these lesions in conjunction with medications is an effective treatment option.
- 12 August 2022
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 13, 354
Open AccessCerebral toxoplasmosis in a patient with combined variable immunodeficiency
Background: Cerebral toxoplasmosis is an opportunistic infection in patients but has rarely been described in the setting of compromised humoral immunodeficiency. Prompt diagnosis and treatment of the infection is critical in the care of these patients. Medical management is the mainstay of treatment of the infection. There have been very few reports of surgical management of cerebral toxoplasmosis. Case Description: We describe the case of a 40-year-old male who presented with headache, memory deficits, weight loss, and left-sided weakness in the setting of a known but undiagnosed brain lesion identified 1 month prior. Imaging demonstrated a right basal ganglia lesion which was initially presumed to be malignancy. On further workup including a positive serum test and biopsy including polymerase chain reaction analysis, diagnosis was confirmed as toxoplasmosis. On further investigation, he was found to have deficiencies in immunoglobulins consistent with common variable immunodeficiency (CVID). The patient underwent craniotomy with surgical debulking as repeat imaging showed increased size of mass with new satellite lesions and worsening hydrocephalus. Conclusion: Cerebral toxoplasmosis is an important differential to consider in cases of intracerebral lesions and should not necessarily be excluded in the absence of compromised cellular immunity. In cases where there is no immunocompromised state and malignancy cannot immediately be established, CVID should be considered as an etiology. Due to the subtlety of CVID diagnosis, careful attention should be paid to history taking and workup for CVID should be considered as soon as possible. Surgical removal of these lesions in conjunction with medications is an effective treatment option.
- 19 July 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (9) , 3655-3662
Characteristics of hair loss after COVID‐19: A systematic scoping review
Objective: While there are literature reporting increased incidence of hair loss in COVID‐19 patients, insufficient evidence exists on the topic to date. This review aims to identify the existing evidence and clinical characteristics of hair loss with COVID‐19 infection.Methods: Following the PRISMA Extension for Scoping Reviews, MEDLINE and EMBASE were searched for all peer‐reviewed articles with relevant keywords including “Alopecia,” “Telogen Effluvium (TE),” and “COVID‐19” from their inception to November 20, 2021.Results: A total of 26 articles, with 9 observational studies and 17 case reports or series (a total of 58 cases), were included. Most studies dealt with TE. There were no clear trends between COVID‐19 severity and the extent of hair loss. Analysis of the 58 cases also found similar results with most of the cases being female (82.8%), the median onset of hair loss of 2.0 months, and the median time to recovery of hair loss of 5.0 months with a resolution rate of 95%.Conclusion: While this systematic review revealed uncertainty and a lack of strong evidence regarding the association of COVID‐19 and hair loss, hair loss in COVID‐19 may mainly include TE and be reversible in nature. Future studies are warranted to determine the detailed pathophysiology and risk factors of hair loss in COVID‐19, including possible roles of estrogen, progesterone, and pro‐inflammatory cytokines.
- 19 July 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (9) , 3655-3662
Characteristics of hair loss after COVID‐19: A systematic scoping review
Objective: While there are literature reporting increased incidence of hair loss in COVID‐19 patients, insufficient evidence exists on the topic to date. This review aims to identify the existing evidence and clinical characteristics of hair loss with COVID‐19 infection.Methods: Following the PRISMA Extension for Scoping Reviews, MEDLINE and EMBASE were searched for all peer‐reviewed articles with relevant keywords including “Alopecia,” “Telogen Effluvium (TE),” and “COVID‐19” from their inception to November 20, 2021.Results: A total of 26 articles, with 9 observational studies and 17 case reports or series (a total of 58 cases), were included. Most studies dealt with TE. There were no clear trends between COVID‐19 severity and the extent of hair loss. Analysis of the 58 cases also found similar results with most of the cases being female (82.8%), the median onset of hair loss of 2.0 months, and the median time to recovery of hair loss of 5.0 months with a resolution rate of 95%.Conclusion: While this systematic review revealed uncertainty and a lack of strong evidence regarding the association of COVID‐19 and hair loss, hair loss in COVID‐19 may mainly include TE and be reversible in nature. Future studies are warranted to determine the detailed pathophysiology and risk factors of hair loss in COVID‐19, including possible roles of estrogen, progesterone, and pro‐inflammatory cytokines.
- 5 June 2022
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 103, 57-61
Clinical characteristics of BRASH syndrome: Systematic scoping review
- 5 June 2022
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 103, 57-61
Clinical characteristics of BRASH syndrome: Systematic scoping review
- Open Access
- 22 February 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (5) , 1155
Procalcitonin to Predict Severity of Acute Cholangitis and Need for Urgent Biliary Decompression: Systematic Scoping Review
Serum procalcitonin (PCT) has been reported as a potential biomarker to predict the severity of acute cholangitis (AC) or the need for urgent biliary decompression. This study aimed to identify and summarize the existing research about serum PCT and the severity of AC, and to find gaps towards which future studies can be targeted. Following the PRISMA extension for scoping reviews, MEDLINE, EMBASE, and Google Scholar were searched for all peer-reviewed articles with relevant keywords including “cholangitis” and “procalcitonin” from their inception to 13 July 2021. We identified six studies. All the studies employed a case-control design and aimed to evaluate the usefulness of serum PCT to predict the severity of AC with key identified outcomes. While the potential cut-off values of serum PCT for severe AC ranged from 1.8–3.1 ng/mL, studies used different severity criteria and the definition of urgent biliary decompression. No studies proposed cut-off PCT values for the need for urgent biliary decompression. This scoping review identified the current level of evidence regarding the usefulness of serum PCT in assessing the severity of AC. Further clinical research is warranted with a focus on standardized outcome measures employing prospective or experimental designs.
- 22 February 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (5) , 1155
Open AccessProcalcitonin to Predict Severity of Acute Cholangitis and Need for Urgent Biliary Decompression: Systematic Scoping Review
Serum procalcitonin (PCT) has been reported as a potential biomarker to predict the severity of acute cholangitis (AC) or the need for urgent biliary decompression. This study aimed to identify and summarize the existing research about serum PCT and the severity of AC, and to find gaps towards which future studies can be targeted. Following the PRISMA extension for scoping reviews, MEDLINE, EMBASE, and Google Scholar were searched for all peer-reviewed articles with relevant keywords including “cholangitis” and “procalcitonin” from their inception to 13 July 2021. We identified six studies. All the studies employed a case-control design and aimed to evaluate the usefulness of serum PCT to predict the severity of AC with key identified outcomes. While the potential cut-off values of serum PCT for severe AC ranged from 1.8–3.1 ng/mL, studies used different severity criteria and the definition of urgent biliary decompression. No studies proposed cut-off PCT values for the need for urgent biliary decompression. This scoping review identified the current level of evidence regarding the usefulness of serum PCT in assessing the severity of AC. Further clinical research is warranted with a focus on standardized outcome measures employing prospective or experimental designs.
- Open Access
- 28 October 2021
- Published by JMIR Publications Inc. in JMIR Infodemiology
- Vol. 1 (1) , e32856
Impact of the World Inflammatory Bowel Disease Day and Crohn’s and Colitis Awareness Week on Population Interest Between 2016 and 2020: Google Trends Analysis
Background: More than 6 million people are affected by inflammatory bowel disease (IBD) globally. The World IBD Day (WID, May 19) and Crohn’s and Colitis Awareness Week (CCAW, December 1-7) occur yearly as national health observances to raise public awareness of IBD, but their effects are unclear. Objective: The aim of this study was to analyze the relationship between WID or CCAW and the public health awareness on IBD represented by the Google search engine query data. Methods: This study evaluates the impact of WID and CCAW on the public awareness of IBD in the United States and worldwide from 2016 to 2020 by using the relative search volume of “IBD,” “ulcerative colitis,” and “Crohn’s disease” in Google Trends. To identify significant time points of trend changes (joinpoints), we performed joinpoint regression analysis. Results: No joinpoints were noted around the time of WID or CCAW during the study period in the search results of the United States. Worldwide, joinpoints were noted around WID in 2020 with the search for “IBD” and around CCAW in 2017 and 2019 with the search for “ulcerative colitis.” However, the extents of trend changes were modest without statistically significant increases. Conclusions: These results posed a question that WID and CCAW might not have worked as expected to raise public awareness of IBD. Additional studies are needed to precisely estimate the impact of health observances to raise the awareness of IBD.
- 28 October 2021
- Published by JMIR Publications Inc. in JMIR Infodemiology
- Vol. 1 (1) , e32856
Open AccessImpact of the World Inflammatory Bowel Disease Day and Crohn’s and Colitis Awareness Week on Population Interest Between 2016 and 2020: Google Trends Analysis
Background: More than 6 million people are affected by inflammatory bowel disease (IBD) globally. The World IBD Day (WID, May 19) and Crohn’s and Colitis Awareness Week (CCAW, December 1-7) occur yearly as national health observances to raise public awareness of IBD, but their effects are unclear. Objective: The aim of this study was to analyze the relationship between WID or CCAW and the public health awareness on IBD represented by the Google search engine query data. Methods: This study evaluates the impact of WID and CCAW on the public awareness of IBD in the United States and worldwide from 2016 to 2020 by using the relative search volume of “IBD,” “ulcerative colitis,” and “Crohn’s disease” in Google Trends. To identify significant time points of trend changes (joinpoints), we performed joinpoint regression analysis. Results: No joinpoints were noted around the time of WID or CCAW during the study period in the search results of the United States. Worldwide, joinpoints were noted around WID in 2020 with the search for “IBD” and around CCAW in 2017 and 2019 with the search for “ulcerative colitis.” However, the extents of trend changes were modest without statistically significant increases. Conclusions: These results posed a question that WID and CCAW might not have worked as expected to raise public awareness of IBD. Additional studies are needed to precisely estimate the impact of health observances to raise the awareness of IBD.
- Open Access
- 12 August 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Impact of the World Inflammatory Bowel Disease Day and Crohn’s and Colitis Awareness Week on Population Interest Between 2016 and 2020: Google Trends Analysis (Preprint)
BACKGROUND More than 6 million people are affected by inflammatory bowel disease (IBD) globally. The World IBD Day (WID, May 19) and Crohn’s and Colitis Awareness Week (CCAW, December 1-7) occur yearly as national health observances to raise public awareness of IBD, but their effects are unclear. OBJECTIVE The aim of this study was to analyze the relationship between WID or CCAW and the public health awareness on IBD represented by the Google search engine query data. METHODS This study evaluates the impact of WID and CCAW on the public awareness of IBD in the United States and worldwide from 2016 to 2020 by using the relative search volume of “IBD,” “ulcerative colitis,” and “Crohn’s disease” in Google Trends. To identify significant time points of trend changes (joinpoints), we performed joinpoint regression analysis. RESULTS No joinpoints were noted around the time of WID or CCAW during the study period in the search results of the United States. Worldwide, joinpoints were noted around WID in 2020 with the search for “IBD” and around CCAW in 2017 and 2019 with the search for “ulcerative colitis.” However, the extents of trend changes were modest without statistically significant increases. CONCLUSIONS These results posed a question that WID and CCAW might not have worked as expected to raise public awareness of IBD. Additional studies are needed to precisely estimate the impact of health observances to raise the awareness of IBD.
- 12 August 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessImpact of the World Inflammatory Bowel Disease Day and Crohn’s and Colitis Awareness Week on Population Interest Between 2016 and 2020: Google Trends Analysis (Preprint)
BACKGROUND More than 6 million people are affected by inflammatory bowel disease (IBD) globally. The World IBD Day (WID, May 19) and Crohn’s and Colitis Awareness Week (CCAW, December 1-7) occur yearly as national health observances to raise public awareness of IBD, but their effects are unclear. OBJECTIVE The aim of this study was to analyze the relationship between WID or CCAW and the public health awareness on IBD represented by the Google search engine query data. METHODS This study evaluates the impact of WID and CCAW on the public awareness of IBD in the United States and worldwide from 2016 to 2020 by using the relative search volume of “IBD,” “ulcerative colitis,” and “Crohn’s disease” in Google Trends. To identify significant time points of trend changes (joinpoints), we performed joinpoint regression analysis. RESULTS No joinpoints were noted around the time of WID or CCAW during the study period in the search results of the United States. Worldwide, joinpoints were noted around WID in 2020 with the search for “IBD” and around CCAW in 2017 and 2019 with the search for “ulcerative colitis.” However, the extents of trend changes were modest without statistically significant increases. CONCLUSIONS These results posed a question that WID and CCAW might not have worked as expected to raise public awareness of IBD. Additional studies are needed to precisely estimate the impact of health observances to raise the awareness of IBD.
- 1 February 2008
- Published by Georg Thieme Verlag KG in Neuropediatrics
- Vol. 39 (01) , V32
Postoperative course and neuropsychological outcome in patients with epileptic encephalopathy after hemispherotomy
Purpose: To identify the postoperative course, the neuropsychological development and the prognostic value of presurgical collected data in a group of patients after hemispherotomy or partial disconnection because of epilepsy and epileptic encephalopathy. Patients and Methods: We analyzed a group of 15 children. The postoperative follow up period was at least 3 months. We examined the postoperative neuropsychological development and changes in the pathological EEG as well as following parameters: (1) age at onset, (2) duration of epilepsy, (3) side of surgery, (4) preoperative seizure frequency, (5) history of epilepsy in the family, (6) trauma, (7) meningitis/encephalitis, (8) complication during pregnancy and birth, (9) febrile convulsions, (10) type of seizures, (11) preoperative deficit in the neurological examination and (12) results of the histological examination. The outcome was measured with the classification scheme of Wieser et al. Results: Three months after surgery 13 children were seizure free. One child showed postoperative complications. Four patients showed a new postoperative hemianopsia additionally, but no patient had a new postoperative hemiparesis. We showed a significant improvement in the neuropsychological development and the EEG results. Conclusions: We showed an excellent outcome after hemispherotomy and partial disconnection in our group of patients. Our patients had an improvement in their neuropsychological development and a decrease of pathological EEG results. Our results demonstrate that children with epileptic encephalopathy benefit from hemispherotomy and have a small postoperative risk of complications.
- 1 February 2008
- Published by Georg Thieme Verlag KG in Neuropediatrics
- Vol. 39 (01) , V32
Postoperative course and neuropsychological outcome in patients with epileptic encephalopathy after hemispherotomy
Purpose: To identify the postoperative course, the neuropsychological development and the prognostic value of presurgical collected data in a group of patients after hemispherotomy or partial disconnection because of epilepsy and epileptic encephalopathy. Patients and Methods: We analyzed a group of 15 children. The postoperative follow up period was at least 3 months. We examined the postoperative neuropsychological development and changes in the pathological EEG as well as following parameters: (1) age at onset, (2) duration of epilepsy, (3) side of surgery, (4) preoperative seizure frequency, (5) history of epilepsy in the family, (6) trauma, (7) meningitis/encephalitis, (8) complication during pregnancy and birth, (9) febrile convulsions, (10) type of seizures, (11) preoperative deficit in the neurological examination and (12) results of the histological examination. The outcome was measured with the classification scheme of Wieser et al. Results: Three months after surgery 13 children were seizure free. One child showed postoperative complications. Four patients showed a new postoperative hemianopsia additionally, but no patient had a new postoperative hemiparesis. We showed a significant improvement in the neuropsychological development and the EEG results. Conclusions: We showed an excellent outcome after hemispherotomy and partial disconnection in our group of patients. Our patients had an improvement in their neuropsychological development and a decrease of pathological EEG results. Our results demonstrate that children with epileptic encephalopathy benefit from hemispherotomy and have a small postoperative risk of complications.